The evidence of benefits of exercise training in interstitial lung disease: A randomised controlled trial

Thorax

Volumn 72, Issue 7, 2017, Pages 610-619

  Dowman, Leona M ^a,b,c   McDonald, Christine F ^b,c,d   Hill, Catherine J ^b,c   Lee, Annemarie L ^c,e   Barker, Kathryn ^f   Boote, Claire ^f   Glaspole, Ian ^g,h   Goh, Nicole S L ^b,c,g   Southcott, Anne M ^f   Burge, Angela T ^a,c,e   Gillies, Rebecca ^a,c   Martin, Alicia ^f   Holland, Anne E ^a,c,e  

^a LA TROBE UNIVERSITY   (Australia)

^b AUSTIN HEALTH   (Australia)

^c INSTITUTE FOR BREATHING AND SLEEP   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Alfred Health ^*  (Australia)

^f WESTERN HEALTH   (Australia)

^g ALFRED HEALTH   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

Asbestos Induced Lung Disease; Connective tissue disease associated lung disease; Exercise; Idiopathic pulmonary fibrosis; Interstitial Fibrosis; Pulmonary Rehabilitation

Indexed keywords

AGED; ASBESTOSIS; CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EXERCISE; FEMALE; HUMAN; IDIOPATHIC PULMONARY FIBROSIS; KINESIOTHERAPY; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TIME FACTOR; VERY ELDERLY; WALK TEST;

AGED; AGED, 80 AND OVER; ASBESTOSIS; DYSPNEA; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PHYSICAL CONDITIONING, HUMAN; QUALITY OF LIFE; SINGLE-BLIND METHOD; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; WALK TEST;

EID: 85027989052     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208638     Document Type: Article

References (40)

1. Demedts M, Wells AU, Anto JM, et al. Interstitial lung disease. An epidemiological overview. Eur Respir J 2001;18:2s-16s.
2. Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med 2014;2:4.
3. Ahluwalia N, Shea BS, Tager AM. New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound healing responses. Am J Respir Crit Care Med 2014;190:867-78.
4. De Lauretis A, Veeraraghavan S, Renzon E. Connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Disease 2011;8:53-82.
5. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63(Suppl 5):v1-58.
6. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
7. Holland AE. Exercise limitation in interstitial lung disease-mechanisms, significance and therapeutic options. Chron Respir Dis 2010;7:101-11.
8. Chang JA, Randall Curtis J, Patrick DL, et al. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999;116:1175-82.
9. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31:1357-67.
10. Mendes P, Wickerson L, Helm D, et al. Skeletal muscle atrophy in advanced interstitial lung disease. Respirology 2015;20:953-9.
11. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014;(10):CD006322.
12. Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration 2014;88:378-88.
13. Dale MT, McKeough ZJ, Munoz PA, et al. Exercise training for asbestos-related and other dust-related respiratory diseases: A randomised controlled trial. BMC Pulm Med 2014;14:180.
14. Holland AE, Hill CJ, Glaspole I, et al. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012;106:429-35.
15. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study. Respir Med 2014;108:203-10.
16. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011;16:1196-202.
17. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease. Benefits and predictors of response. Chest 2009;135:442-7.
18. Dowman L, McDonald CF, Hill C, et al. The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trial. BMC Pulm Med 2013;13:8.
19. Dowman L, McDonald CF, Hill CJ, et al. Reliability of the hand held dynamometer in measuring muscle strength in people with interstitial lung disease. Physiotherapy 2016;102:249-55.
20. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax 2010;65:921-6.
21. Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of a new dyspnea measure. The UCSD Shortness of Breath Questionnaire. Chest 1998;113:619-24.
22. Mahler DA, Harver A, Rosiello R, et al. Measurement of respiratory sensation in interstitial lung disease. Evaluation of clinical dyspnea ratings and magnitude scaling. Chest 1989;96:767-71.
23. Tzanakis N, Maria Samiou T, Lambiri I, et al. Evaluation of health related quality of life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Int Med 2005;16:105-12.
24. Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008;63:549-54.
25. Holland AE, Hill CJ, Conron M, et al. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med 2009;103:1430-5.
26. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996;49:1215-19.
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Pscychiatr Scand 1983;67:361-70.
28. Swigris JJ, Brown KK, Behr J, et al. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2010;104:296-304.
29. De Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002;121:1092-8.
30. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008;13:394-9.
31. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215-20.
32. Suissa S. Lung function decline in COPD trials: bias from regression to the mean. Eur Resp J 2008;32:829-31.
33. Frost AE, Langleben D, Oudiz R, et al. The 6-min walk test (6MWT) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol 2005;43:36-9.
34. Spruit MA, Singh SJ, Garvey C, et al., on behalf of the ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64.
35. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/ American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-46.
36. Li M, Mathur S, Chowdhury NA, et al. Pulmonary rehabilitation in lung transplant candidates. J Heart Lung Transplant 2013;32:626-32.
37. Wickerson L, Mathur S, Brooks D. Exercise training after lung transplantation: A systematic review. J Heart Lung Transplant 2010;49:457-503.
38. Langer D, Burtin C, Schepers L, et al. Exercise training after lung transplantation improves participation in daily activity: A randomized controlled trial. Am J Transplant 2012;12:1584-92.
39. Pollock M, Gaesser GA, Butcher JD, et al. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30:975-91.
40. Jones P, Lareau S, Mahler DA. Measuring the effects of COPD on the patient. Respir Med 2005;99(Suppl B):S11-18.